Long QT Syndrome: How Effective Therapy in a Single Patient Favorably Influenced the Long-Term Clinical Course and Genetic Understanding of this Hereditary Disorder

Progress in Cardiovascular Diseases

Volumn 58, Issue 2, 2015, Pages 221-226

  Lowengrub, Katherine M ^a   Moss, Deborah R ^b   Moss, David A ^c   Moss, Arthur J ^d  

^a TEL AVIV UNIVERSITY   (Israel)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c HARVARD BUSINESS SCHOOL   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Long QT Syndrome; LQTS Genetics; LQTS Registry

Indexed keywords

PROPRANOLOL; GENETIC MARKER;

ARTICLE; CERVICOTHORACIC SYMPATHETIC GANGLIONECTOMY; DISEASE COURSE; DISEASE REGISTRY; DOCTOR PATIENT RELATION; ELECTROCARDIOGRAM; FAINTNESS; GANGLIONECTOMY; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DISORDER; HUMAN; LOCAL ANESTHESIA; LONG QT SYNDROME; LONG TERM CARE; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; POLYMORPHIC VENTRICULAR TACHYCARDIA; PREVALENCE; PUBLIC-PRIVATE PARTNERSHIP; PUBLICATION; QT INTERVAL; STELLATE GANGLION BLOCK; SYMPATHETIC NERVE; UNITED STATES; COOPERATION; DEATH, SUDDEN, CARDIAC; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HEREDITY; HISTORY; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; MORTALITY; MUTATION; PATHOPHYSIOLOGY; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE; REGISTER; RISK FACTOR; TREATMENT OUTCOME;

COOPERATIVE BEHAVIOR; DEATH, SUDDEN, CARDIAC; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERNATIONAL COOPERATION; LONG QT SYNDROME; MUTATION; PEDIGREE; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84942087810     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.08.002     Document Type: Article

References (28)

1. Moss A.J., Osborne R.K., Baue A.E., Lees R.S., Jamison R.L., Spann J. Closed-chest cardiac massage in the treatment of ventricular fibrillation complicating acute myocardial infarction. N Engl J Med 1962, 267:679-681.
2. Moss A.J., Bruhn F. The echocardiogram. An ultrasound technic for the detection of pericardial effusion. N Engl J Med 1966, 274:380-384.
3. Moss A.J., Rivers R.J., Griffith L.S., Carmel J.A., Millard E.B. Transvenous left atrial pacing for the control of recurrent ventricular fibrillation. N Engl J Med 1968, 278:928-931.
4. Moss A.J., Glaser W., Topol E. Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension. N Engl J Med 1980, 302:1456-1457.
5. Moss A.J., McDonald J. Unilateral cervicothoracic sympathetic ganglionectomy for the treatment of long QT interval syndrome. N Engl J Med 1971, 285:903-904.
6. Jervell A., Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957, 54:59-68.
7. Levine S.A., Woodworth C.R. Congenital deaf-mutism, prolonged QT interval, syncopal attacks and sudden death. N Engl J Med 1958, 259:412-417.
8. Moss A.J., Schwartz P.J. 25th anniversary of the International Long-QT Syndrome Registry: an ongoing quest to uncover the secrets of long-QT syndrome. Circulation 2005, 111:1199-1201.
9. Moss A.J., Schwartz P.J., Crampton R.S., Locati E., Carleen E. The long QT syndrome: a prospective international study. Circulation 1985, 71:17-21.
10. Moss A.J., Schwartz P.J., Crampton R.S., et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 1991, 84:1136-1144.
11. Keating M., Dunn C., Atkinson D., Timothy K., Vincent G.M., Leppert M. Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet 1991, 49:1335-1339.
12. Wang Q., Curran M.E., Splawski I., et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12:17-23.
13. Wang Q., Shen J., Li Z., et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet 1995, 4:1603-1607.
14. Schwartz P.J., Ackerman M.J., George A.L., Wilde A.A. Impact of genetics on the clinical management of channelopathies. J Am Coll Cardiol 2013, 62:169-180.
15. Zareba W., Moss A.J., Schwartz P.J., et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998, 339:960-965.
16. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001, 103:89-95.
17. Goldenberg I., Moss A.J., Zareba W., et al. Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. J Cardiovasc Electrophysiol 2006, 17:1161-1168.
18. Moss A.J., Shimizu W., Wilde A.A., et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007, 115:2481-2489.
19. Shimizu W., Moss A.J., Wilde A.A., et al. Genotype-phenotype aspects of type 2 long QT syndrome. J Am Coll Cardiol 2009, 54:2052-2062.
20. Goldenberg I., Bradley J., Moss A., et al. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol 2010, 21:893-901.
21. Abu-Zeitone A., Peterson D.R., Polonsky B., McNitt S., Moss A.J. Efficacy of different beta-blockers in the treatment of long QT syndrome. J Am Coll Cardiol 2014, 64:1352-1358.
22. Ouriel K., Moss A.J. Long QT syndrome: an indication for cervicothoracic sympathectomy. Cardiovasc Surg 1995, 3:475-478.
23. Moss A.J., Daubert J.P. Images in clinical medicine. Internal ventricular defibrillation. N Engl J Med 2000, 342:398.
24. Kolder I.C., Tanck M.W., Postema P.G., et al. Analysis for genetic modifiers of disease severity in patients with long-QT syndrome type 2. Circ Cardiovasc Genet 2015, 8:447-456.
25. Kass R.S., Moss A.J. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest 2003, 112:810-815.
26. Moss A.J., Kass R.S. Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 2005, 115:2018-2024.
27. Moss A.J., Windle J.R., Hall W.J., et al. Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial. Ann Noninvasive Electrocardiol 2005, 10:59-66.
28. Moss A.J., Zareba W., Schwarz K.Q., Rosero S., McNitt S., Robinson J.L. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol 2008, 19:1289-1293.